Detailed Information on Publication Record
2015
Busulphane and treosulphane in therapy of pediatric solid tumors
MAZÁNEK, Pavel, Ludmila MALÁŠKOVÁ, Tomáš KEPÁK and Peter MÚDRYBasic information
Original name
Busulphane and treosulphane in therapy of pediatric solid tumors
Authors
MAZÁNEK, Pavel (203 Czech Republic, guarantor, belonging to the institution), Ludmila MALÁŠKOVÁ (203 Czech Republic), Tomáš KEPÁK (203 Czech Republic, belonging to the institution) and Peter MÚDRY (203 Czech Republic, belonging to the institution)
Edition
XXV. Konference dětských hematologů a onkologů České a Slovenské republiky, 2015
Other information
Language
English
Type of outcome
Konferenční abstrakt
Field of Study
30200 3.2 Clinical medicine
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
RIV identification code
RIV/00216224:14110/15:00085319
Organization unit
Faculty of Medicine
ISBN
978-80-210-7958-8
Keywords (in Czech)
busulfan; treosulfan; ewingův sarkom; neuroblastom; farmakokinetika
Keywords in English
busulfan; treosulfan; Ewing's sarcoma; neuroblastoma; pharmacokinetics
Tags
Změněno: 18/12/2015 10:12, Ing. Mgr. Věra Pospíšilíková
Abstract
V originále
Busulfan and treosulfan are strong alkylating agents with significant antitumor myeloablative and immunosupresive potential. Both these preparations are integral consolidation treatment of high-risk pediatric solid tumors, particularly neuroblastoma (NBL) and Ewing's sarcoma (ES) either at the time of primary therapy as well as in the treatment of relapse of these diseases.